A	B	C	D	E	F	G	H	I	J	K	L	M	N	O	P	Q	R
1	Main
2
3			Q120	Q220	Q320	Q420	Q121	Q221	Q321	Q421	Q122	Q222	Q322	Q422	Q123	Q223	Q323	Q423
4		US					4892	4355			6097	5846
5		North America					5101	4529			6323	6032
6		Europe					2785	2695			3050	2551
7		China					775	794			910	1001
8		Asia-Pac					1709	1749			2064	2042
9		Other					311	300			381	345
10
11		Life Sciences					4203	3292			4231	3292
12		Analytical Instruments					1387	1607			1518	1607
13		Diagnostics					1615	1101			1482	1101
14		Lab Products & Biopharma Services					3597	5537			5442	5537
15
16		Consumables					5964	5372			6110	4993
17		Instruments					1892	1842			1907	2010
18		Product	4630				7856	7214			8017	7003
19		Services	1600				2050	2059			3801	3967
20		Revenue	6230				9906	9273			11818	10970
21		COP	2340				3327	3352			3555	3516
22		COS	1150				1370	1397			2799	2855
23		COGS	3490				4697	4749			6354	6371
24		Gross Margin	2740				5209	4524			5464	4599
25		SG&A	1551				1826	1899			2277	2209
26		R&D	245				320	343			364	365
27		Operating Expenses	1796				2146	2242			2641	2574
28		Operating Income	944				3063	2282			2823	2025
29		Interest Income	-78				-296	-114			-281	-84
30		Pretax Income	866				2767	2168	0	0	2542	1941
31		MI+Taxes	40				416	221			325	253
32		Net Income	826				2351	1947	0	0	2217	1688
33		EPS	2.065				5.92191435768262	4.916666666666667			5.612658227848101	4.284263959390863
34		Shares	400				397	396			395	394
35
36
37		Product y/y									0.020493890020366612	-0.02924868311616302
38		Services y/y									0.8541463414634147	0.9266634288489557
39		Revenue y/y									0.19301433474661822	0.18300442143858509
40		Product GM%					0.5765020366598778	0.5353479345716662			0.5565672944991892	0.49792945880337
41		Services GM%					0.33170731707317075	0.32151529868868384			0.26361483820047354	0.28031257877489285
42		Gross Margin					0.5258429234807187	0.4878680038822388			0.46234557454730074	0.41923427529626256
43
44
45		Net Debt					-13062	-11754			-30503	-28372
46		Cash					5583	7023			2752	1888
47		AR					5554	5476			7889	7445
48		Inventories					4342	4625			5483	5668
49		Contract					783	804			1064	1147
50		OCA					1423	1332			1588	1652
51		PP&E					6133	6560			8448	8529
52		Goodwill					39654	39294			61099	59644
53		Other					2459	2584			4424	4306
54		Assets					65931	67698			92747	90279
55
56		Debt					18645	18777			33255	30260
57		AP					2146	2098			2667	2586
58		Employees					1314	1492			1634	1722
59		Contract					1396	1470			2871	2722
60		OA					2135	1861			3032	2957
61		DT					1885	1632			3493	3327
62		OLTL					3352	3514			4664	4534
63		MI					0	0			113	117
64		SE					35058	36854			41018	42354
65		L+SE					65931	67698			92747	90579
66
67		Model NI					2351	1947			2217	1688
68		Reported NI					2337	1829			2220	1668
69		Depreciation					198	211			250	236
70		Intangibles					423	449			609	600
71		DT					24	-331			-339	-262
72		Early Debt					197	0			26	0
73		SBC					51	51			78	77
74		Non-Cash					69	144			233	58
75		WC					-1321	-126			-875	-849
76		CFFO					1978	2227			2202	1528
77
78		Acquisitions					-1343	-82			-40	0
79		CapEx					-628	-540			-640	-506
80		Sale of PPE					5	0			2	12
81		Other					-32	-4			8	75
82		CFFI					-1998	-626			-670	-419
83
84		Debt					-2803	0			-1008	-1825
85		Buyback					-2000	0			-2000	0
86		Dividends					-87	-103			-103	-117
87		ESOP					20	52			2	49
88		Other					20	-25			-36	-12
89		CFFF					-4850	-76			-3145	-1905
90
91		FX					137	-93			-99	-78
92		CIC					-4733	1432			-1712	-874
93
94		FCF					1350	1687			1562	1022